For research and education only · Not reviewed by a medical professional · Disclaimer · Contains affiliate links

Peptide encyclopedia/ Human insulin
Illustration for Human insulin

THE PEPSRADAR ENCYCLOPEDIA

Human insulin

Blood-glucose regulation

Prescription medicines · Sources checked 2026-10-04

Read the studies ↓Explore the molecule ↗

Human insulin AT A GLANCE

The question behind the molecule.

Read findings and limitations ↓
1 selected publicationContext mattersDifferent insulin products have different time courses and are not interchangeable by name alone.

What is Human insulin?

Human insulin replaces or supplements insulin activity in diabetes. Different formulations have different onset and duration, making product identity especially important.

Biological role or research focus

Blood-glucose regulation.

Different insulin products have different time courses and are not interchangeable by name alone.

Role reference: MedlinePlus · Human insulin ↗

Names you may encounter

insulin

Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.

Class / identity
Glucose-regulating hormone
Main research area
Diabetes management
Evidence featured
Human randomized trial
Source check
October 4, 2026

Source: MedlinePlus · Human insulin ↗

Molecular structure

Human insulin: 2d molecular structure. Mature human insulin is shown. Insulin analogues and formulation additives are not included.⤢ Enlarge 2D
2D molecular structureMature human insulin is shown. Insulin analogues and formulation additives are not included.PubChem · CID 118984375 ↗

Mechanism & research rationale

Insulin helps tissues take up glucose and reduces the liver’s glucose output. Formulation changes alter the time course of that activity.

Source: MedlinePlus · Human insulin ↗

Clinical uses & product context

It is central to type 1 diabetes care and used in selected people with type 2 diabetes. DCCT examined the benefits and risks of an intensive management strategy, including frequent monitoring.

Source: MedlinePlus · Human insulin ↗

What does the evidence show?

Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.

Human randomized trial · 1993

DCCT

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Population / model
1,441 people with type 1 diabetes, with or without early retinopathy.
Study design
Intensive versus conventional diabetes treatment; average follow-up 6.5 years.
Main finding
Intensive management reduced development of retinopathy by 76% in the primary-prevention group and slowed progression by 54% in the other group. Severe hypoglycemia was more frequent.
Limits & context
This tested a treatment strategy including monitoring, not one modern brand versus another. It demonstrates the tradeoff between complication reduction and hypoglycemia risk.

Source: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. ↗

Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.

Further reading · 4 additional publication links

Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.

Downstream processing of recombinant human insulin and its analogues production from E. coli inclusion bodies. ↗
Bioresources and bioprocessing · 2021 · Journal Article, Review
Read available full text ↗

Human insulin. ↗
British medical journal (Clinical research ed.) · 1986 Jan 18 · Editorial
Read available full text ↗

Expression in Escherichia coli of chemically synthesized genes for human insulin. ↗
Proceedings of the National Academy of Sciences of the United States of America · 1979 Jan · Journal Article
Read available full text ↗

Human insulin. ↗
BMJ (Clinical research ed.) · 1989 Oct 21 · Journal Article, Review
Read available full text ↗

Repeat this PubMed search ↗
Search additional PubMed records ↗

New editorial updates

Loading approved updates…

New source discoveries

Links appear automatically. Unreviewed discoveries are not verified medical findings.

Loading recent discoveries…

Explore the latest source feed →

Safety & precautions

Key precautions

Hypoglycemia can be severe or life-threatening. Product, concentration, timing, meals, illness, and activity affect risk. This page is a research reference and does not calculate or recommend insulin doses.

Source: MedlinePlus · Human insulin ↗

This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.

What are people discussing?

No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.

Watch the source discussions

378 matching video records · 18 with captions indexed.

Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.

Browse all 378 matching videos →

Sources & supplier listings

Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.

No verified matching catalog listing yet

We have not added a supplier for this profile. Missing products and coded listings are not filled with guesses.

Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.

Questions worth asking

  • Which indication and formulation does the source describe?
  • Does the video make a broader claim than the source supports?
  • Different insulin products have different time courses and are not interchangeable by name alone.
  • What adverse effects, uncertainty, and conflicts of interest does the original source report?

Frequently asked questions

Is every insulin product interchangeable?

No. Time-action profiles and concentrations differ; substitution requires the correct clinical instructions.

Source: MedlinePlus · Human insulin ↗

Did DCCT identify one best insulin brand?

No. It compared management strategies, not all modern products head to head.

Source: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. ↗

References & editorial record

Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.

For research and education only. This page does not provide medical advice, diagnosis, or treatment. Research-only listings are not instructions for human use.

WATCH ON PEPSRADAR

Watch video

MOLECULAR ATLAS

Human insulin

Download illustration ↓Source record ↗
Human insulin 2d molecular structure

Mature human insulin is shown. Insulin analogues and formulation additives are not included.